Sana'a:An expanded meeting was held at Sana'a University, chaired by the Minister of Health and Environment, Dr. Ali Shaiban, along with the University Rector, Dr. Mohammed Al-Bukhaiti, to explore cooperation and strategic partnership with the pharmaceutical industry.
According to Yemen News Agency, the meeting aimed to advance the national pharmaceutical sector, localize medicine production, and achieve pharmaceutical security. It included discussions with the Chairman of the Supreme Board of Medicines, Dr. Amin Qabas, the Secretary-General of the Union of Pharmaceutical Manufacturers, Abdul Rahman Al-Alfi, and representatives from pharmaceutical companies and manufacturing plants.
The discussions focused on leveraging scientific research and postgraduate studies to address the needs and challenges of the pharmaceutical industry and the labor market. There was also an emphasis on directing master's and doctoral research towards these objectives.
Additionally, the meeting addressed the potential for contributing to the completion and equipping of the Bioavailability and Bioequivalence Center and proposed constructing two lecture halls for the medical faculties, with joint funding from the university and pharmaceutical companies.
Minister Shaiban highlighted the vital role of Sana'a University in preparing national talent and emphasized the importance of strengthening strategic partnerships with the private sector to develop the pharmaceutical industry and enhance education and services quality.
Dr. Al-Bukhaiti reaffirmed the university's commitment to aligning education and research with development needs, particularly in the pharmaceutical sector. He noted that the Bioavailability and Bioequivalence Center would provide significant scientific and technical support for local pharmaceutical testing and evaluation.
The meeting concluded with the formation of a joint committee to draft a memorandum of understanding outlining cooperation areas and mechanisms for implementing the proposed projects, including the completion of the Bioavailability and Bioequivalence Center and the construction of lecture halls.
